In the present study, we have investigated whether the AhR ligand FICZ can alleviate the adverse cardiac remodeling that occurs during the initial phase of pressure overload induced by transverse aortic constriction (TAC). This evidence concerns the gene AHR and persistent truncus arteriosus.